Below are the best articles we could find on Psychedelic Research and depression.
CLEAR ALL
At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.
1
In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.
Amazonian healing traditions collide with Western medical sensibilities.
2
The first randomized controlled trial to compare the illicit psychedelic psilocybin with a conventional selective serotonin reuptake inhibitor (SSRI) antidepressant found that the former improved symptoms of depression just as well on an established metric—and had fewer side effects.
Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.
To treat depression, the neurons which control the hormones serotonin and dopamine in our brains seem to get all the attention.
The antidepressant effects of the psychedelic brew known as ayahuasca appear to be related to anti-inflammatory activity, according to new research from scientists in Brazil.
The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.
A new generation of research into psilocybin could change how we treat numerous mental health conditions.
Some experts view ketamine as a tool to unravel the biological causes of depression and, perhaps someday, cure it.
To continue customizing your FindCenter experience, create an account. It’s free!
Create an account to discover wisdom, save your favorite content, and connect with teachers and seekers.
IT’S FREE
If you already have an account, please log in.
